Zinc Protoporphyrin IX and Its Antitumor Effects
Author Information
Author(s): Nowis Dominika, Bugajski Marek, Winiarska Magdalena, Bil Jacek, Szokalska Angelika, Salwa Pawel, Issat Tadeusz, Was Halina, Jozkowicz Alicja, Dulak Jozef, Stoklosa Tomasz, Golab Jakub
Primary Institution: Medical University of Warsaw
Hypothesis
Can zinc protoporphyrin IX (Zn(II)PPIX), a heme oxygenase-1 inhibitor, enhance the antitumor effects of chemotherapeutics?
Conclusion
Inhibition of HO-1 exerts antitumor effects but should not be used to potentiate antitumor effects of cancer chemotherapeutics unless procedures of selective tumor targeting of HO-1 inhibitors are developed.
Supporting Evidence
- Zn(II)PPIX induced significant accumulation of reactive oxygen species in tumor cells.
- Zn(II)PPIX exerted potent cytostatic/cytotoxic effects against human and murine tumor cell lines.
- Zn(II)PPIX was unable to potentiate antitumor effects of 5-fluorouracil, cisplatin, or doxorubicin in three different tumor models.
Takeaway
Zinc protoporphyrin IX can help fight tumors, but it doesn't make chemotherapy work better.
Methodology
The study used crystal violet staining, clonogenic assays, Western blotting, and flow cytometry to evaluate the effects of Zn(II)PPIX on tumor cells.
Limitations
The study did not explore the timing of Zn(II)PPIX administration in combination with chemotherapeutics.
Participant Demographics
The study involved murine models, specifically BALB/c and C57Bl/6 mice.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website